medicare

On Thursday, Senate Republicans unveiled their revised healthcare reform bill. Here’s everything you need to know. ‘Skinny’ Policies  The new bill allows insurers to sell “skinny” insurance plans that don’t meet the minimum coverage requirements currently in...

Analysts at Citi initiates coverage of Aetna Inc (NYSE: AET) with a Buy rating, $180 price target and named to the firm's "Citi Focus List." Aetna should be viewed as a "strong diversified health insurer" that is also well positioned to gain share within the government segment and has "stable...

Republicans in Congress promised to repeal the Affordable Care Act on the first day of a new GOP administration. Five months later, the overhaul remains stalled, just one part of an agenda paralyzed by the probe into President Donald Trump’s dealings with Russia. The U.S. Senate is working on...

It’s going to be busy this week in the healthcare industry, with several key developments on the schedule that could have a major impact on the U.S. healthcare sector. What A Week First, on Monday, the Centers for Medicare and Medicaid Services released the latest batch of Health Insurance...

Argus in a note released on Friday upgraded shares of Humana Inc (NYSE: HUM), with the upgrade premised on the belief that the company has strong growth prospects as an independent company following the termination of its merger agreement with Aetna Inc (NYSE: AET). The Annulled Deal Aetna...

The poor, the elderly, the disabled, college students and environmental protections all stand to take a big hit if Congress approves President Donald Trump’s $4.1 trillion budget for fiscal year 2018. Defense contractors, corporations in general and the wealthiest Americans all stand to gain...

Shares of Pfizer Inc. (NYSE: PFE) were trading lower by nearly 2 percent Tuesday morning after analysts at Citi downgraded the stock and offered three alternative recommendations. Citi's Andrew Baum downgraded Pfizer's stock rating from Neutral to Sell with a price target slashed from $38 to $31....

EXACT Sciences Corporation (NASDAQ: EXAS) plummeted over 7 percent Monday on a Citron Research report predicting a 40-percent short-term value concession and long-term drop to a near-zero single digit. Citron's most important report in YEARS. $EXAS to trade short term $20. Long term much lower...

Build a business model based on marginalized Medicare recipients living in poor, urban neighborhoods where doctors rarely care or dare to set up shop. Focus on quality health care with a holistic view of a patient’s needs, from house calls to behavioral counseling to transportation to that...

Somewhere beyond the cacophony over President Donald Trump’s firing of FBI Director James Comey is a steady, behind-the-scenes hum about healthcare, which won’t stay yesterday’s news for very long. Analysts at Height Securities, LLC say the U.S. Senate has to deal with healthcare...

Republicans have proposed to repeal the Affordable Care Act, colloquially known as "Obamacare," and are seeking approval for the new GOP healthcare bill dubbed Trumpcare. President Donald Trump has proposed significant tax cuts to reduce healthcare expense, with Medicaid expected to bear most of...

Notwithstanding the broader market rally, pharmacy benefit managers, or PBMs, saw weakness on Wednesday amid fears that President Donald Trump has his eyes trained on this space. The reason? Trump is apparently suspecting these companies are colluding with drug manufacturers in jacking up prices...

Although President-elect Donald Trump's victory spells higher chances for the regulatory approval of the $37 billion merger between Aetna Inc (NYSE: AET) and Humana Inc (NYSE: HUM), the antitrust suit on the deal amplifies the difficulty the firms face in trying to get the nod of approval from...

Citing the uncertainty surrounding President-elect Donald Trump's healthcare ground rules, Jefferies said it is a select buyer of managed healthcare organizations, heading into 2017. The firm noted that MCOs are pricing in the possible Medicare upside. Humana: Risk/Reward Attractive Analyst...

With the Republicans in control of Capitol Hill, the outlook for Social Security in its current iteration is uncertain as many party members argue for sweeping reforms to Social Security to reduce government spending. Add to that the unreliability of President-elect Donald Trump's rhetoric...